Theme Thinking commercial during drug discovery and development

General

Program

14:30 The Johnson & Johnson Innovation collaboration model
          Tess Korthout | Early Innovation Partner, J&J Innovation

14:45 Developing a commercial strategy during discovery and early development
          Erik Holl | Managing Director, the Netherlands, J&J Innovative Medicine

15:05 The Target Product Profile as your North Star
          Justine Donnelly, Senior Director, Head of Global Brand & Commercial Strategy Excellence, Global Commercial Strategy Organization (GCSO), J&J*

15:25 Break

15:45 Bridge to commercial thinking as a start-up

          Eric Ciamporcero | Head of the Preclinical and Translational Science, 2 Bridge

16:05 Panel Discussion
          Gopal Rajan | Scientific Director, Global Head PPDS Scientific Integration, J&J
          Peter Roevens | External Innovation Partner, J&J
          Bernd van Buuren | CEO & CO-Founder, Protinhi Therapeutics

          Maria Grazia Pau | Senior Director, Compound Development Team Leader, J&J
          Els Eerdekens | Therapeutic Area Lead IDV/GPH, Global Development, J&J (moderator)

16:45 Audience Q&A

17:00 Informal Q&A
In-person attendees only

18:00 Event close

Date and Location

Time From 2.30 pm to 6.00 pm
Duration 3.5 hours
Start date Thursday, May 23, 2024
Location Noviotech Campus, Nijmegen (NL) & Virtual

Costs and registration